Back to Results

Extendicare Inc (EXETF)

Extendicare Inc. is a Canadian healthcare company focused on seniors’ care and related services. Through its subsidiaries, it operates across three segments: long-term care, home health care, and managed services. The long-term care business includes accommodation, meals, and support with daily living and continuing care for residents. Its home health care operations provide nursing care, occupational therapy, speech therapy, and assistance with everyday activities. The managed services segment includes management, consulting, and other services supplied to third parties and joint ventures. The company conducts business under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. Incorporated in 1968 and based in Markham, Canada, Extendicare is listed as common stock on OTC Markets under the symbol EXET.F.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-EXET.F
$16.20
-26.1% Downside
Overvalued
Not available
Not available
Great
September 30, 2026
October 15, 2026
1.7%
November 5, 2026
24.7x
7.4x
1.5x
2.103 B
2.504 B
18.0%
98.8%
3.2
37.6%
81.0%
Valuation • Fair Value

Extendicare Inc (OTC-EXET.F) Fair Value by Valuation Model

Review the available estimates for Extendicare Inc (OTC-EXET.F), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$16.20

Estimated downside of 26.1% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$18.51

Discounted cash flow valuation reference.

Ben Graham Formula Value

$10.09

Classic Ben Graham valuation formula reference.

DDM Fair Value

$11.42

Dividend discount model valuation reference.

Comps Fair Value

$15.49

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 6 available valuation references for Extendicare Inc (OTC-EXET.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Extendicare Inc (OTC-EXET.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.395 B

Current operating scale indicator.

Revenue Forecast

1.644 B

Forward revenue estimate.

EBITDA

146.3 M

Current operating profitability reference.

EBITDA Forecast

183.9 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Extendicare Inc (OTC-EXET.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Extendicare Inc (OTC-EXET.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-1.44

Higher caution zone on this screen.

Altman Z-Score

3.2

Relatively strong balance-sheet zone.

FCF / Net Income

81.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Extendicare Inc (OTC-EXET.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Extendicare Inc (OTC-EXET.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 5, 2026

Days to Earnings

44

Dividend Payment Date

October 15, 2026

Ex-Dividend Date

September 30, 2026

Dividend Yield

1.7%

Current income yield reference.

Payout Ratio

37.6%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Extendicare Inc (OTC-EXET.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Extendicare Inc (OTC-EXET.F) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Extendicare Inc (OTC-EXET.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Extendicare Inc (OTC-EXET.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Extendicare Inc (OTC-EXET.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Extendicare Inc (OTC-EXET.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Extendicare Inc (OTC-EXET.F) Stock FAQ

Data-supported answers about Extendicare Inc (OTC-EXET.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$16.20
Estimated downside 26.1%
Valuation Rating
Overvalued
Estimated downside of 26.1%
Financial Health
Great
Current financial-health read

The current fair value estimate for Extendicare Inc (OTC-EXET.F) is $16.20. This implies an estimated downside of 26.1% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 26.1% versus the current market price.

The current financial health read for Extendicare Inc (OTC-EXET.F) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Extendicare Inc (OTC-EXET.F) is November 5, 2026.

Based on the current data, dividend yield is 1.7%, ex-dividend date is September 30, 2026, payment date is October 15, 2026.

The current P/E ratio listed for Extendicare Inc (OTC-EXET.F) is 24.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Extendicare Inc is 2.103 B.

The current enterprise value listed for Extendicare Inc is 2.504 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Extendicare Inc is OTC-EXET.F, and the stock is listed on OTC Markets.

Extendicare Inc (OTC-EXET.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Extendicare Inc is 18.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Extendicare Inc is 98.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Undervalued Market Cap 334.8 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 111.4 B
MCK NYSE McKesson Corporation Fair Value Undervalued Market Cap 103.9 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 94.854 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 87.275 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 72.333 B
COR NYSE Cencora Inc Fair Value Fair Market Cap 60.002 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 51.415 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 44.67 B
CNC NYSE Centene Corp Fair Value Undervalued Market Cap 31.27 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 25.911 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 25.266 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 23.774 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.101 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.111 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 11.925 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 11.79 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.716 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 10.567 B
ENSG NASDAQ The Ensign Group Inc Fair Value Fair Market Cap 10.19 B